JP Morgan reported in their recent outlook piece that "The backdrop for the European consumer is also improving. Real wages ...

Intel is scheduled to report second-quarter results after the closing bell Thursday, with analysts tracked by Visible Alpha unanimously neutral amid questions surrounding the company's foundry ...

Wall Street's biggest bull sees tech and AI driving an 11% stock gain, fueled by strong fundamentals, M&A activity, and ...

Analysts expect the Stamford, Connecticut-based company to report quarterly earnings at $1.86 per share, up from $1.59 per ...

Pharmaceutical stocks are in focus as President Trump's drug tariff deadline looms. Yahoo Finance Senior Reporter Anjalee ...

In the recent 13F filings, Pfizer has seen a mix of investment adjustments from 11 institutions, reflecting a divided market ...

US stocks remain narrowly mixed amid more earnings reports. Investors are looking for impact of Trump's tariffs. Chip stocks weigh on Nasdaq, S&P 500.

Eli Lilly faces a pivotal moment as its stock experiences a slight pullback. Investors are eyeing its upcoming earnings ...